Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tetsuya Matoba, Hiroaki Shimokawa, Mikio Nakashima, Yoji Hirakawa, Yasushi Mukai, Katsuya Hirano, Hideo Kanaide, Akira Takeshita
Published in Volume 106, Issue 12
J Clin Invest. 2000; 106(12):1521–1530 doi:10.1172/JCI10506
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

ACh-induced production of H2O2 by the endothelium. DCF-dependent fluorescence intensities (determined 3 minutes after application of ACh) are expressed as fold increase from that under basal conditions. (a) ACh (10 μM) caused a significant increase in fluorescence intensity. Pretreatment with indomethacin (10 μM), L-NNA (100 μM), or both did not affect the responses (n = 5–7). NS, not significant. (b) Inhibitory effect of catalase on the ACh-induced increase in fluorescence intensity (n = 4–7). (c) The ACh-induced increase in fluorescence intensity was significantly reduced in eNOS-KO mice (n = 4). Experiments were performed in the presence of indomethacin (10 μM) and L-NNA (100 μM). (d) Inhibitory effect of calmodulin antagonists calmidazolium (10 μM) and fendiline (100 μM) on the ACh-induced increase in fluorescence intensity (n = 5–6). Indo, indomethacin (10 μM); Cat, catalase (1250 U/ml). AP < 0.05 by one-way ANOVA; BP < 0.05 vs. basal condition by paired Student’s t test.